New data confirms Cardiac Dimensions Carillon System shows favorable longterm survival rate in patients with functional mitral regurgitation

New data confirms Cardiac Dimensions’ Carillon System shows favorable long-term survival rate in patients with functional mitral regurgitation

03:03 EST 28 Feb 2020 | Compelo Medical Devices

Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure (HF), today announced the findings of

More From BioPortfolio on "New data confirms Cardiac Dimensions’ Carillon System shows favorable long-term survival rate in patients with functional mitral regurgitation"